Anti-FXYD6 monoclonal antibody

Anti-FXYD6 antibody for FACS & in-vivo assay

Target products collectionGo to FXYD6/FXYD6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0458-Ab-1/ GM-Tg-hg-MP0458-Ab-2Anti-Human FXYD6 monoclonal antibodyHuman
GM-Tg-rg-MP0458-Ab-1/ GM-Tg-rg-MP0458-Ab-2Anti-Rat FXYD6 monoclonal antibodyRat
GM-Tg-mg-MP0458-Ab-1/ GM-Tg-mg-MP0458-Ab-2Anti-Mouse FXYD6 monoclonal antibodyMouse
GM-Tg-cynog-MP0458-Ab-1/ GM-Tg-cynog-MP0458-Ab-2Anti-Cynomolgus/ Rhesus macaque FXYD6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0458-Ab-1/ GM-Tg-felg-MP0458-Ab-2Anti-Feline FXYD6 monoclonal antibodyFeline
GM-Tg-cang-MP0458-Ab-1/ GM-Tg-cang-MP0458-Ab-2Anti-Canine FXYD6 monoclonal antibodyCanine
GM-Tg-bovg-MP0458-Ab-1/ GM-Tg-bovg-MP0458-Ab-2Anti-Bovine FXYD6 monoclonal antibodyBovine
GM-Tg-equg-MP0458-Ab-1/ GM-Tg-equg-MP0458-Ab-2Anti-Equine FXYD6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0458-Ab-1/ GM-Tg-hg-MP0458-Ab-2; GM-Tg-rg-MP0458-Ab-1/ GM-Tg-rg-MP0458-Ab-2;
GM-Tg-mg-MP0458-Ab-1/ GM-Tg-mg-MP0458-Ab-2; GM-Tg-cynog-MP0458-Ab-1/ GM-Tg-cynog-MP0458-Ab-2;
GM-Tg-felg-MP0458-Ab-1/ GM-Tg-felg-MP0458-Ab-2; GM-Tg-cang-MP0458-Ab-1/ GM-Tg-cang-MP0458-Ab-2;
GM-Tg-bovg-MP0458-Ab-1/ GM-Tg-bovg-MP0458-Ab-2; GM-Tg-equg-MP0458-Ab-1/ GM-Tg-equg-MP0458-Ab-2
Products NameAnti-FXYD6 monoclonal antibody
Formatmab
Target NameFXYD6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FXYD6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FXYD6 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0458
    Target NameFXYD6
    Gene ID53826,59095,63847,698456,610831,101087344,511064,100062824
    Gene Symbol and Synonyms0610030I18Rik,FXYD6,Php
    Uniprot AccessionQ9H0Q3,Q91XV6,Q3MHZ5
    Uniprot Entry NameFXYD6_HUMAN,FXYD6_RAT,FXYD6_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000137726
    Target ClassificationN/A

    The target: FXYD6, gene name: FXYD6, also named as . This gene encodes a member of the FXYD family of transmembrane proteins. This particular protein encodes phosphohippolin, which likely affects the activity of Na,K-ATPase. Multiple alternatively spliced transcript variants encoding the same protein have been described. Related pseudogenes have been identified on chromosomes 10 and X. Read-through transcripts have been observed between this locus and the downstream sodium/potassium-transporting ATPase subunit gamma (FXYD2, GeneID 486) locus.[provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.